Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)
Sponsor: ECOG-ACRIN Cancer Research Group
This NA trial investigates Acute Promyelocytic Leukemia With PML-RARA and t(15;17) and is currently ongoing. ECOG-ACRIN Cancer Research Group leads this study, which shows 21 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
21 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Sep 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
Phase: None → NA
-
Dec 2024 — May 2025 [monthly]
Active Not Recruiting
▶ Show 16 earlier versions
-
Nov 2024 — Dec 2024 [monthly]
Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Jul 2023 — Dec 2023 [monthly]
Active Not Recruiting
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting
-
Feb 2023 — Jun 2023 [monthly]
Active Not Recruiting
-
Jan 2022 — Feb 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Jun 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2018 — Jun 2020 [monthly]
Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Sep 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ECOG-ACRIN Cancer Research Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .